Arvinas, Inc. (ARVN) shares soared 8.8% in the last trading session to close at $9.03. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics (JANX), 479% surge in interest Fortress Biotech (FBIO), 440% surge in interest Dogwood Therapeutics (DWTX), 248% surge in ...
In this article, we are going to take a look at where Arvinas, Inc. (NASDAQ:ARVN) stands against the other small-cap ...
Hosted on MSN15d
Wall Street Analysts Predict a 228.87% Upside in Arvinas (ARVN): Here's What You Should KnowArvinas, Inc. (ARVN) closed the last trading session at $17.70, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
Wedbush became the latest brokerage to downgrade Arvinas (NASDAQ:ARVN) on Wednesday after the company posted underwhelming late-stage trial data for vepdegestrant, an experimental breast cancer ...
Guggenheim analyst Michael Schmidt maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report) yesterday and set a price target of $57.00. The company’s shares closed yesterday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback